Stargardt’s Disease and related inherited macular dystrophies typically begin affecting central vision at a young age, making everyday tasks like reading and recognizing faces increasingly difficult, while peripheral vision generally remains stable for a longer period. India has become a trusted destination for **Stargardt’s or Macular Dystrophy treatment for patients from Pakistan**, though it remains important to note that a definitive cure for this inherited macular condition is still a complex and ongoing pursuit within the medical field.
As part of a broader Stargardt’s / macular dystrophy treatment approach, stem cell-based therapy is considered a developing area of interest for patients whose macular cells are progressively affected. This treatment avenue is explored for its potential to support the macula’s surviving cell population, offering young patients and their families an additional option to discuss alongside standard low-vision support.
Within a structured Stargardt’s / macular dystrophy treatment protocol, Mesenchymal stem cell injections given via the Retro-bulbar route have become a widely used approach, typically delivered over one or two sessions. This method has shown an encouraging track record in supporting the regenerative response of macular and photoreceptor cells, with relevance extending to macular cells, photoreceptor cells, and retinal pigment epithelium cells.
Families from Pakistan navigating a Stargardt’s diagnosis are encouraged to connect with the Eye Stem Cell Center, which brings more than 12 years of focused experience with inherited macular conditions. Our specialists review fundus autofluorescence imaging, OCT, and ERG reports carefully before advising any family on next steps.
Eye Stem Cell Center is one of the most trusted providers of Stargardt’s or Macular Dystrophy treatment in Pakistan.

